Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
23.85
-0.31 (-1.28%)
Sep 26, 2025, 2:45 PM CST
SHA:600645 Market Cap
SHA:600645 has a market cap or net worth of 10.85 billion as of September 26, 2025. Its market cap has increased by 45.12% in one year.
Market Cap
10.85B
Enterprise Value
9.40B
Revenue
1.50B
Ranking
n/a
PE Ratio
144.13
Stock Price
23.85
Market Cap Chart
Since May 9, 2006, SHA:600645's market cap has increased from 610.06M to 10.85B, an increase of 1,678.56%. That is a compound annual growth rate of 16.00%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 26, 2025 | 10.85B | 23.32% |
Dec 31, 2024 | 8.80B | -7.24% |
Dec 29, 2023 | 9.49B | 19.17% |
Dec 30, 2022 | 7.96B | -32.61% |
Dec 31, 2021 | 11.81B | 28.71% |
Dec 31, 2020 | 9.18B | 15.82% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 467.24B |
WuXi AppTec | 299.68B |
Shenzhen Mindray Bio-Medical Electronics | 288.50B |
Sichuan Biokin Pharmaceutical | 149.53B |
Zhangzhou Pientzehuang Pharmaceutical., | 119.01B |
Shanghai United Imaging Healthcare | 118.35B |
Aier Eye Hospital Group | 114.80B |
Yunnan Baiyao Group Co.,Ltd | 101.90B |